Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm
1. Kuehn Law is investigating Corcept Therapeutics for potential self-dealing. 2. The investigation targets officers and directors for breaching fiduciary duties. 3. Shareholders could pursue damages and corporate governance reforms. 4. Long-term CORT stockholders are encouraged to participate in the investigation.